| Table of contents Farm Hosp. vol.39 n.5 Toledo Sep./Oct. 2015 Press Release | | | |
Originals | | | | · Patient safety: prescription of drugs that prolong the QT interval Hernández-Arroyo, María Jesús; Díaz-Madero, Alfonso; Menacho-Miguel, David
| | | | · Development of integrated support software for clinical nutrition Siquier Homar, Pedro; Pinteño Blanco, Manel; Calleja Hernández, Miguel Ángel; Fernández Cortés, Francisco; Martínez Sotelo, Jesús
| | | | · Validation of cold chain during distribution of parenteral nutrition Tuan, Federico; Perone, Virginia; Verdini, Rocío; Pell, María Betina; Traverso, María Luz
| | | | · Off-label use of oncology drugs: national survey results González-Haba Peña, Eva; Agustín Ferrández, María José; Mangues Bafalluy, Irene; López, Nicolás Alfredo; Fraga Fuentes, María Dolores; Marín Gil, Roberto; Martínez Bautista, María José; Clopés Estela, Ana; SEFH. GRUPO GEDEFO (Grupo de Farmacia Oncológica, GENESIS (Grupo de Evaluación de Novedades, Estandarización e Investigación en Selección de medicamentos)
| | | | · Economic evaluation in collaborative hospital drug evaluation reports Ortega, Ana; Fraga, María Dolores; Marín-Gil, Roberto; López-Briz, Eduardo; Puigventós, Francesc; Dranitsaris, George
| | | Opinion Article | | | | · Vedolizumab in Crohn Disease genesis-sefh drug evaluation report González Chávez, Jenifer; Asensi Díez, Rocío; Tamayo Bermejo, Rocío; Alegre del Rey, Emilio Jesús; Martínez López de Castro, Noemí
| | | Brief Communication | | | | · Causal analysis and impact of a systematic error detected about consumption associated with trastuzumab Bujaldón Querejeta, Nuria; Camacho Romera, Dolores; Pomares Pastor, José Antonio; Sánchez Garnes, María; Martínez Ramírez, Mauricio; González Delgado, Mercedes
| | | Letters to the Editor | | | | · Switching therapy from natalizumab to fingolimod: reduction of the washout time? Sánchez-Gundín, Julia; Flor García, Amparo; Martí Gil, Caridad; Gómez Romero, Lourdes
| | |
|